Cargando…
Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report
BACKGROUND: Metabolic syndrome (MS) is known to be associated with hypertension, insulin resistance, and dyslipidemia, and it raises the risk for cardiovascular diseases and diabetes mellitus. Telmisartan is used in clinic as an angiotensin II receptor blocker and it is also identified as activating...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290862/ https://www.ncbi.nlm.nih.gov/pubmed/30584345 http://dx.doi.org/10.2147/DMSO.S187092 |